Hepatitis C, B, D, and A
- 14 March 2001
- journal article
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 20 (1) , 9-17
- https://doi.org/10.1300/j069v20n01_02
Abstract
Over 90% of intravenous heroin addicts (IVHAs) carry the hepatitis C virus (HCV). The other hepatitis viruses, A, B, D, and G are relatively unimportant in IVHAs compared to HCV although active hepatitis B may demonstrate a chronic, degenerative course identical to that of HCV. The clinical course of HCV and active hepatitis B may span three or more decades. It is helpful to classify patients as in the active, cirrhosis, or liver failure stages. Only in the active, early stage are the liver enzymes, ALT and AST, likely to be elevated. It is this stage that will most likely respond to antiviral therapy. HCV has so many extra-hepatic manifestations including immune suppression, collagen diseases, and possibly lymphoma and leukemia that the disease is best termed HCV syndrome rather than simple hepatitis.Keywords
This publication has 10 references indexed in Scilit:
- Hepatitis CThe Lancet, 1998
- Hepatitis CAnnals of Internal Medicine, 1996
- Seroprevalence of Hepatitis A, B, C, and D Markers and Liver Function Abnormalities in Intravenous Heroin AddictsJournal of Addictive Diseases, 1995
- Hepatocellular carcinomaPostgraduate Medicine, 1993
- Alanine aminotransferase measurements and histological disease in hepatitis CThe Lancet, 1993
- Prevalence of hepatitis C in a chemically dependent populationArchives of internal medicine (1960), 1993
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with CirrhosisAnnals of Internal Medicine, 1992
- Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccineThe American Journal of Medicine, 1986
- Heroin-induced thrombocytopeniaArchives of internal medicine (1960), 1979